What Are the Challenges Faced During the National Phase?
The national phase can be challenging due to varying patent laws and regulations across different countries. Researchers and companies may face hurdles such as high costs, language barriers, and different patentability criteria. In the context of cancer, where speed is critical, delays in securing patents can impact the commercialization and availability of life-saving treatments. Navigating these challenges requires strategic planning and often involves working with local patent attorneys.
